THE FACT ABOUT MBL77 THAT NO ONE IS SUGGESTING

Not all patients with CLL call for therapy. Despite all modern advances, the iwCLL even now recommends watchful observation for sufferers with asymptomatic disease.86 This recommendation is based on not less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).. i